A total of 89 deaths have been reported following COVID-19 vaccination till March 16, but none of the fatalities has been attributed to the inoculation so far, Rajya Sabha was informed on Tuesday.
In written reply to a question, Minister of State for Health Ashwini Choubey said that adverse events following immunization (AEFI) are monitored through a well-structured and robust surveillance system.
Causality assessment of all serious and severe AEFI cases is done by a designated committee to determine if an adverse event is related to the vaccine or vaccination process or otherwise, he said.
Adequate measures have been put in place to manage AEFI cases like availability of anaphylaxis kits at each vaccination site, immediate referral to AEFI management centre and observation of vaccine recipients for 30 minutes at session site so as to take timely corrective measure.
Also, the AEFI management of such cases are provided free-of-cost treatment in public health facilities.
"As on March 16, 2021, a total of 89 deaths of vaccinated persons have been reported.... None of the deaths so far have been causally attributed to COVID-19 vaccination as per the current evidence," Choubey said.
Responding to another question on the agency which developed CoWIN app being used for vaccine development and whether the code has been open-sourced, Choubey said the application has been developed by the Ministry of Health with technical support from the United Nations Development Programme (UNDP).
The code used for developing Co-WIN are open source and all concerned APIs are available on 'API Setu' initiative of the Government of India, he said.
At time of registration for vaccination, the beneficiaries' name, gender, year of birth and government photo ID number are collected.
"This data is entered by the beneficiary themselves at time of registration for vaccination and no agency is authorised to collect this data. The personal data of beneficiaries of COVID-19 vaccine conforms to data security and confidentiality norms," the minister stated.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)